Work on stem cells is one of the hottest research areas in biology. But are such studies of any therapeutic value? Fortunately, yes, as is evident from successes in treating blindness.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Rama, P. et al. N. Engl. J. Med. 363, 147–155 (2010).
Pellegrini, G., Rama, P., Mavilio, F. & De Luca, M. J. Pathol. 217, 217–228 (2009).
Dua, H. S. & Azuara-Blanco, A. Surv. Ophthalmol. 44, 415–425 (2000).
Thomas, E. D., Lochte, H. L. Jr, Lu, W. C. & Ferrebee, J. W. N. Engl. J. Med. 257, 491–496 (1957).
Barrandon, Y. & Green, H. Proc. Natl Acad. Sci. USA 84, 2302–2306 (1987).
Green, H. Sci. Am. 265, 96–102 (1991).
Pellegrini, G. et al. J. Cell Biol. 145, 769–782 (1999).
Senoo, M., Pinto, F., Crum, C. P. & McKeon, F. Cell 129, 523–536 (2007).
Pellegrini, G. et al. Lancet 349, 990–993 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ezhkova, E., Fuchs, E. An eye to treating blindness. Nature 466, 567–568 (2010). https://doi.org/10.1038/466567a
Published:
Issue Date:
DOI: https://doi.org/10.1038/466567a
This article is cited by
-
A matter of life and death: self‐renewal in stem cells
EMBO reports (2013)